Killer Stocks

 Free stock investing Blog.  Invest at your own risk 19 Sept 2022 Our third Stock pick Geodrill is yet another potential buyout candidate over the next 12 months. GEO .TO or GEODF on OCTQX  Closing Price  $2.50 CDN or 1.90 US 1. Geodrill is a potential takeover target,. The CEO has made it clear he's ready to retire but no buyer yet and CEO is doing an excellent job to continue growing the company and paying a dividend now as well. CEO David Harper started the company with one drill rig and one contract in 1998. 2.  Recent youtube video by Radius Research will give you a lot of info on the company.  https://www.youtube.com/watch?v=43Ofg-_DpPg 3. Geodrill uplisted recently to the 2nd tier OTCQX  making it easier for US investors to purchase this interesting small cap company. It looked like it was going for a nice runup then the market crash happened.  I think this presents a good buying opportunity. 4.  Geodrill is a leading exploration drill...

 Free Stock Blog. Invest at your own risk. RGD.V  Current Price 0.365 CDN. Gold, Gold and more Gold.  1. The biggest new gold find in years. Possible 10 to 12 million ounces worth 17 to 20 Billion US$. It will be a buyout candidate by one of major Gold companies.  2. Unfortunately they had to dilute shares as lot and now have almost a billion shares. But current market cap is less than 400 million CDN and they have 50 million plus CDN in the bank. 3. Rick Rule video on BNN is a good one to watch for info. Its the 3rd stock featured in this video. https://www.bnnbloomberg.ca/video/rick-rule-s-top-picks~251322 4. Well financed with 50+ million CDN in bank and 2 more drills added recently.  Postponed Resource estimate until 2023 because they are still expanding this big deposit. 5. I bought this stock at $ 0.11 CDN so consider that as well, but I am holding all my stock until it's bought out by a major gold mining company. It should have a good chance of doubling ...

 Free stock research blog. Invest at your own risk. www.oncolyticsbiotech.com  ONCY NASDAQ  ONC.TO   Currently  1.31$ US 1.71 CDN I could write a 500 page book on why I think Oncolytics Biotech is a good stock to buy but the Focus of this investment Blog is to keep things simple.  With a Title and 5 main Points to buy each of our 5 stocks that we think have potential to double in value. Pancreatic Cancer,  Pancreatic Cancer,   Pancreatic Cancer.  1. There are no good treatments for Pancreatic Cancer a cancer that has killed several high profile people in recent years including Steve Jobs CEO of Apple,  Alex Trebeck of Jeopardy fame and many others. 2 new people with experience in Biotech and buyouts have been recently added to Oncolytics Biotech’s BOD 2.  Oncolytics Biotech along with Big Pharma company Roche did a 3 patient safety study with the cancer killing virus pelareorep and Roche's CI drug Tecentriq and chemo and a...

 New Blog starting on 16 September 2022. Plan is to feature ONLY 5 stocks per year, that will have at least a possibility to double in a year. We will be looking for undervalued and turnaround situations with ability to provide good Gains for investors. Please invest at your own risk We are investors with experience,  but as always there are no Guarantees. So it will be easy to follow because we will be only covering a few stocks per year. Our First Stock Pick is Oncolytics Biotech  ONCY on NASDAQ and ONC on Toronto exchange.  Current Price is 1.72 CDN and 1.31 US. We believe that Oncolytics Biotech will be bought by Roche or Pfizer in less than a year and possibly within 6 months or less. A bidding war between the two big Pharmas is  possible. See next message for investment thesis.